The results indicated that IGF2BP2 silencing decreased the malignant behaviors of CRC cells in proliferation (Fig. 7J), colony formation (Fig. 7K–L), migration, and invasion (Fig. 7M–O) induced by FTO and ALKBH5 silence. Here, IGF2BP2 is linked to colorectal carcinoma.